Review



antibody against d1 dopamine receptors  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Bioss antibody against d1 dopamine receptors
    Antibody Against D1 Dopamine Receptors, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against d1 dopamine receptors/product/Bioss
    Average 94 stars, based on 1 article reviews
    antibody against d1 dopamine receptors - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Bioss antibody against d1 dopamine receptors
    Antibody Against D1 Dopamine Receptors, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against d1 dopamine receptors/product/Bioss
    Average 94 stars, based on 1 article reviews
    antibody against d1 dopamine receptors - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs primary antibodies against d1r
    Primary Antibodies Against D1r, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against d1r/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    primary antibodies against d1r - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Bioss antibody against d 1 dopamine receptors
    Antibody Against D 1 Dopamine Receptors, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against d 1 dopamine receptors/product/Bioss
    Average 93 stars, based on 1 article reviews
    antibody against d 1 dopamine receptors - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc antibodies against dopamine receptor d1
    Antibodies Against Dopamine Receptor D1, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against dopamine receptor d1/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    antibodies against dopamine receptor d1 - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    90
    21st Century Biochemicals antibody against the d1-like dopamine receptor, dop1
    (A) Schematic of the Ae. aegypti brain superimposed on a scanned electron microscope image [34]. Highlighted regions include the AL (multicolored to represent individual glomeruli that receive input from olfactory receptor neurons) and the mushroom bodies (MB), implicated in learning and memory. The open box around the AL is used to indicate the corresponding location in panels (B)–(D). CX, central complex; OL, optic lobes. Scale bar, 500 μm. (B) Confocal micrograph of a whole Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (magenta) shows immunoreactivity concentrated in the lateral protocerebrum and AL. Background fluorescence in green. Scale bar, 100 μm. (C) Confocal micrograph of a Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (cyan) shows heterogeneous innervation of dopaminergic neurons across antennal lobe glomeruli. Open box bounds the right AL. Background fluorescence in green. Scale bar, 60 μm. (D) A 60 μm section of Ae. aegypti brain stained with antibodies against the mosquito dopamine-1 receptor-1 <t>Dop1</t> (yellow) shows these receptors enriched in the lateral protocerebrum around the MB as well as localized around the AL. Background fluorescence in blue (synapsin). Scale bar, 100 μm. (E) A representative section from the same brain that was preadsorbed with a synthetic peptide corresponding to amino acids 138–154 of Dop1 shows synapsin immunoreactivity (blue), but Dop1 immunoreactivity (yellow) is abolished. Scale bar, 100 mm. See also Figures S4 and S6.
    Antibody Against The D1 Like Dopamine Receptor, Dop1, supplied by 21st Century Biochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibody against the d1-like dopamine receptor, dop1/product/21st Century Biochemicals
    Average 90 stars, based on 1 article reviews
    antibody against the d1-like dopamine receptor, dop1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Bioss antibodies against drd1
    Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated <t>dopamine</t> <t>D1</t> <t>receptors</t> ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group
    Antibodies Against Drd1, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against drd1/product/Bioss
    Average 90 stars, based on 1 article reviews
    antibodies against drd1 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology goat primary antibody against the dopamine d1 receptor sc31479
    Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated <t>dopamine</t> <t>D1</t> <t>receptors</t> ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group
    Goat Primary Antibody Against The Dopamine D1 Receptor Sc31479, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat primary antibody against the dopamine d1 receptor sc31479/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    goat primary antibody against the dopamine d1 receptor sc31479 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology affinity-purified rabbit antibody against the dopamine d1 receptor
    Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated <t>dopamine</t> <t>D1</t> <t>receptors</t> ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group
    Affinity Purified Rabbit Antibody Against The Dopamine D1 Receptor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/affinity-purified rabbit antibody against the dopamine d1 receptor/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    affinity-purified rabbit antibody against the dopamine d1 receptor - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Novus Biologicals mouse monoclonal antibody against d1 dopamine receptors
    Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated <t>dopamine</t> <t>D1</t> <t>receptors</t> ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group
    Mouse Monoclonal Antibody Against D1 Dopamine Receptors, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal antibody against d1 dopamine receptors/product/Novus Biologicals
    Average 94 stars, based on 1 article reviews
    mouse monoclonal antibody against d1 dopamine receptors - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic of the Ae. aegypti brain superimposed on a scanned electron microscope image [34]. Highlighted regions include the AL (multicolored to represent individual glomeruli that receive input from olfactory receptor neurons) and the mushroom bodies (MB), implicated in learning and memory. The open box around the AL is used to indicate the corresponding location in panels (B)–(D). CX, central complex; OL, optic lobes. Scale bar, 500 μm. (B) Confocal micrograph of a whole Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (magenta) shows immunoreactivity concentrated in the lateral protocerebrum and AL. Background fluorescence in green. Scale bar, 100 μm. (C) Confocal micrograph of a Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (cyan) shows heterogeneous innervation of dopaminergic neurons across antennal lobe glomeruli. Open box bounds the right AL. Background fluorescence in green. Scale bar, 60 μm. (D) A 60 μm section of Ae. aegypti brain stained with antibodies against the mosquito dopamine-1 receptor-1 Dop1 (yellow) shows these receptors enriched in the lateral protocerebrum around the MB as well as localized around the AL. Background fluorescence in blue (synapsin). Scale bar, 100 μm. (E) A representative section from the same brain that was preadsorbed with a synthetic peptide corresponding to amino acids 138–154 of Dop1 shows synapsin immunoreactivity (blue), but Dop1 immunoreactivity (yellow) is abolished. Scale bar, 100 mm. See also Figures S4 and S6.

    Journal: Current biology : CB

    Article Title: Modulation of Host Learning in Aedes aegypti Mosquitoes

    doi: 10.1016/j.cub.2017.12.015

    Figure Lengend Snippet: (A) Schematic of the Ae. aegypti brain superimposed on a scanned electron microscope image [34]. Highlighted regions include the AL (multicolored to represent individual glomeruli that receive input from olfactory receptor neurons) and the mushroom bodies (MB), implicated in learning and memory. The open box around the AL is used to indicate the corresponding location in panels (B)–(D). CX, central complex; OL, optic lobes. Scale bar, 500 μm. (B) Confocal micrograph of a whole Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (magenta) shows immunoreactivity concentrated in the lateral protocerebrum and AL. Background fluorescence in green. Scale bar, 100 μm. (C) Confocal micrograph of a Ae. aegypti brain stained with antibodies against tyrosine hydroxylase (cyan) shows heterogeneous innervation of dopaminergic neurons across antennal lobe glomeruli. Open box bounds the right AL. Background fluorescence in green. Scale bar, 60 μm. (D) A 60 μm section of Ae. aegypti brain stained with antibodies against the mosquito dopamine-1 receptor-1 Dop1 (yellow) shows these receptors enriched in the lateral protocerebrum around the MB as well as localized around the AL. Background fluorescence in blue (synapsin). Scale bar, 100 μm. (E) A representative section from the same brain that was preadsorbed with a synthetic peptide corresponding to amino acids 138–154 of Dop1 shows synapsin immunoreactivity (blue), but Dop1 immunoreactivity (yellow) is abolished. Scale bar, 100 mm. See also Figures S4 and S6.

    Article Snippet: The antibody against the D1-like dopamine receptor, Dop1 was custom made by 21st Century Biochemicals against a synthetic peptide corresponding to amino acids 138–154 of the Ae. aegypti protein, affinity purified, and used at a concentration of 1:100 for immunohistochemistry.

    Techniques: Microscopy, Staining, Fluorescence

    (A) Left: Dopamine receptor antagonists (DAA) (SCH-23390, bulbocapnine, flupentixol, and fluphenazine) were injected in the thorax of 6-day-old female mosquitoes that were trained 30 min post injection and tested 24 hr later. Center: Dop1 and control dsRNA were injected in 1-day-old pupae, and after 6 days post emergence, mosquitoes were trained and tested. Right: CRISPR/Cas9 constructs were injected in embryos. Mutants were backcrossed, screened and selected by sequencing for five to eight generations before being trained at 6 days old. (B–D) Mosquito choice in the olfactometer represented as a preference index. Trained mosquitoes from the Rockefeller, Liverpool strain, saline-injected, and dsRNA-injected Rockefeller lines were not significantly different in their learning performances (p > 0.05, binomial test; black bars). By contrast, mosquitoes injected with dopamine receptor antagonists (blue-green bars), dsRNA-injected (red bar), and CRISPR mosquitoes (blue bar) showed no learning. Mosquitoes injected with dopamine receptor antagonists (SCH-23398, 10−6 M) or dsRNA, as well as CRISPR mosquitoes, were still responding to positive controls such as CO2 (C) or host odors (D). When human scents were used during training, CRISPR mosquitoes showed no learning (p = 0.79, binomial test). Each bar (mean ± SE) representing 11–29 responsive female mosquitoes; asterisks indicate distributions that are significantly different from random (p < 0.05, binomial test); # indicates p < 0.06 when the response of the trained CRISPR was compared to chance. See also Figures S2 and S4.

    Journal: Current biology : CB

    Article Title: Modulation of Host Learning in Aedes aegypti Mosquitoes

    doi: 10.1016/j.cub.2017.12.015

    Figure Lengend Snippet: (A) Left: Dopamine receptor antagonists (DAA) (SCH-23390, bulbocapnine, flupentixol, and fluphenazine) were injected in the thorax of 6-day-old female mosquitoes that were trained 30 min post injection and tested 24 hr later. Center: Dop1 and control dsRNA were injected in 1-day-old pupae, and after 6 days post emergence, mosquitoes were trained and tested. Right: CRISPR/Cas9 constructs were injected in embryos. Mutants were backcrossed, screened and selected by sequencing for five to eight generations before being trained at 6 days old. (B–D) Mosquito choice in the olfactometer represented as a preference index. Trained mosquitoes from the Rockefeller, Liverpool strain, saline-injected, and dsRNA-injected Rockefeller lines were not significantly different in their learning performances (p > 0.05, binomial test; black bars). By contrast, mosquitoes injected with dopamine receptor antagonists (blue-green bars), dsRNA-injected (red bar), and CRISPR mosquitoes (blue bar) showed no learning. Mosquitoes injected with dopamine receptor antagonists (SCH-23398, 10−6 M) or dsRNA, as well as CRISPR mosquitoes, were still responding to positive controls such as CO2 (C) or host odors (D). When human scents were used during training, CRISPR mosquitoes showed no learning (p = 0.79, binomial test). Each bar (mean ± SE) representing 11–29 responsive female mosquitoes; asterisks indicate distributions that are significantly different from random (p < 0.05, binomial test); # indicates p < 0.06 when the response of the trained CRISPR was compared to chance. See also Figures S2 and S4.

    Article Snippet: The antibody against the D1-like dopamine receptor, Dop1 was custom made by 21st Century Biochemicals against a synthetic peptide corresponding to amino acids 138–154 of the Ae. aegypti protein, affinity purified, and used at a concentration of 1:100 for immunohistochemistry.

    Techniques: Injection, Control, CRISPR, Construct, Sequencing, Saline

    Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated dopamine D1 receptors ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group

    Journal: Acta Pharmacologica Sinica

    Article Title: Isosibiricin inhibits microglial activation by targeting the dopamine D1/D2 receptor-dependent NLRP3/caspase-1 inflammasome pathway

    doi: 10.1038/s41401-019-0296-7

    Figure Lengend Snippet: Isosibiricin upregulates dopamine D1/2 receptors expressions in LPS-induced BV-2 cells. a , b The predicted pathways ( a ) and targets ( b ) of isosibiricin inferred by the differential expressed gene-based method. c , d Isosibiricin upregulated dopamine D1 receptors ( c ) and dopamine D2 receptor ( d ) expressions in LPS-induced BV-2 cells. ## P < 0.01 vs. control group. ** P < 0.01 vs. LPS group

    Article Snippet: Antibodies against DRD1 and DRD2 were obtained from Bioss (Beijing, China).

    Techniques: